rs2104286 — IL2RA

IL2RA — The T-Regulatory Cell Thermostat

The IL2RA gene¹¹ IL2RA gene
IL2RA encodes CD25, the alpha chain of the interleukin-2 receptor, which forms the high-affinity IL-2 receptor when combined with beta and gamma chains encodes CD25, the alpha subunit of the interleukin-2 receptor. IL-2 signaling through this receptor is the central pathway²² central pathway
IL-2 is essential for Treg development, survival, and suppressive function; CD25 deficiency causes fatal autoimmunity in mice and humans for maintaining regulatory T cells (Tregs) — the immune cells responsible for preventing your immune system from attacking your own tissues. The rs2104286 variant, located in the first intron of IL2RA, alters how much of the receptor gets shed from the cell surface as soluble IL-2RA (sIL-2RA), competing with membrane-bound receptors³³ competing with membrane-bound receptors
Soluble IL-2RA binds and sequesters IL-2, reducing the amount available to activate Tregs on the cell surface for available IL-2. This variant has emerged as one of the most consistently replicated non-HLA autoimmune risk loci⁴⁴ non-HLA autoimmune risk loci
Genome-wide association studies have identified IL2RA as a shared susceptibility locus across multiple autoimmune conditions, with associations across multiple sclerosis, type 1 diabetes, and other autoimmune conditions.

The Mechanism

IL-2 signaling acts as the master switch for Treg homeostasis⁵⁵ master switch for Treg homeostasis
IL-2 receptor signaling drives STAT5 phosphorylation, which activates FoxP3 transcription and maintains Treg identity. When IL-2 binds the high-affinity receptor complex (CD25/CD122/CD132), it triggers JAK-STAT signaling, particularly STAT5 phosphorylation⁶⁶ STAT5 phosphorylation
pSTAT5 is the dominant downstream signal in Tregs, directly driving FoxP3 expression and Treg suppressive capacity, which is essential for Treg survival and function. The rs2104286 risk allele (T on the plus strand, reported as A in coding-strand notation) alters IL2RA methylation patterns⁷⁷ IL2RA methylation patterns
The risk allele changes allele-specific methylation at a CpG site in intron 1, affecting transcriptional regulation in the first intron, increasing IL2RA gene expression and elevating levels of soluble IL-2RA (sIL-2RA) in the bloodstream.

The paradox is critical: more IL2RA expression does not mean better IL-2 signaling. The excess receptor is shed from the cell surface as sIL-2RA, which acts as a decoy⁸⁸ acts as a decoy
sIL-2RA binds IL-2 with moderate affinity, sequestering it away from membrane-bound receptors on Tregs, sequestering IL-2 before it can activate membrane-bound receptors on Tregs. Studies show an inverse correlation between sIL-2RA and IL-2 response⁹⁹ inverse correlation between sIL-2RA and IL-2 response
Correlation coefficient -0.581 (p=0.0003) between serum sIL-2RA and STAT5 phosphorylation response — higher sIL-2RA levels correlate with reduced pSTAT5 signaling in CD4+CD25hi T cells. The net effect is impaired Treg function with an intact Treg population: the cells are present but understimulated.

This mechanism has direct implications for gut immunity. Intestinal Tregs depend on IL-2 signaling for differentiation and maintenance at mucosal sites¹⁰¹⁰ differentiation and maintenance at mucosal sites
Effector Tregs in the gut require IL-2R signaling for terminal differentiation; reduced signaling impairs mucosal immune tolerance. Impaired Treg function at the gut barrier can compromise oral tolerance — the process by which the immune system learns to tolerate food antigens and commensal bacteria rather than mounting inflammatory responses against them.

The Evidence

A meta-analysis of 11 studies¹¹¹¹ meta-analysis of 11 studies
Xiao et al. pooled 8,608 MS cases and 9,061 controls across Caucasian and Asian populations encompassing 8,608 multiple sclerosis patients and 9,061 controls established the risk allele association with OR 1.19 (95% CI: 1.13-1.25, p < 0.001) in Caucasians and OR 1.25 (95% CI: 1.01-1.55, p = 0.041) in Asians. A large Canadian cohort study¹²¹² large Canadian cohort study
Traboulsee et al. studied 1,978 MS patients and 830 controls from the Canadian Collaborative Project on Genetic Susceptibility to MS confirmed the protective C allele with OR 0.87 (95% CI: 0.74-1.03), showing strongest effects in sporadic MS cases without family history (OR 0.77, p = 0.05).

The variant's role extends to type 1 diabetes, where IL2RA was identified as a shared autoimmune susceptibility locus¹³¹³ shared autoimmune susceptibility locus
Maier et al. demonstrated rs2104286 risk allele increases sIL-2RA levels in both MS and T1D cohorts with the protective allele associated with OR 0.80 (95% CI: 0.76-0.85, p = 1.27x10^-13). Genotype-stratified sIL-2RA measurements in T1D cases showed a clear dose-response: TT homozygotes (AA in coding notation) had the highest sIL-2RA levels (2.811 ng/ml), heterozygotes were intermediate (2.574 ng/ml), and protective CC homozygotes (GG in coding notation) had the lowest (2.281 ng/ml).

Functional studies in healthy genotype-selected controls¹⁴¹⁴ Functional studies in healthy genotype-selected controls
Cerosaletti et al. demonstrated reduced pSTAT5 in CD4+CD25hi T cells from risk haplotype carriers, with increased naive Treg CD25 expression but paradoxically impaired signaling confirmed that risk allele carriers show decreased pSTAT5 in CD4+CD25hi T cells despite increased surface CD25 expression on naive Tregs — confirming the sIL-2RA shedding mechanism rather than reduced receptor expression as the cause of impaired signaling. Additional associations include intermediate uveitis¹⁵¹⁵ intermediate uveitis
Lindner et al. identified parallel autoimmune pathways shared with MS.

Practical Implications

The key insight from this variant is that your Treg function may be compromised not because you lack Tregs, but because IL-2 signaling to those Tregs is dampened. This creates a specific therapeutic target: strategies that support Treg function and IL-2 signaling.

Vitamin D has emerged as particularly relevant for IL2RA risk allele carriers. Clinical studies¹⁶¹⁶ Clinical studies
Prietl et al. showed vitamin D supplementation significantly increased Treg percentages in healthy subjects demonstrate that 1,25-dihydroxyvitamin D3 directly promotes Treg differentiation through the VDR/PLC-gamma1/TGF-beta1 pathway¹⁷¹⁷ VDR/PLC-gamma1/TGF-beta1 pathway
Vitamin D activates VDR on T cells, upregulating PLC-gamma1 and TGF-beta1 to drive FoxP3+ Treg differentiation, providing an IL-2-independent route to bolster Treg numbers and function. This is especially relevant when IL-2 signaling is genetically impaired.

Omega-3 fatty acids (EPA and DHA) offer another Treg-supportive pathway. Research demonstrates¹⁸¹⁸ Research demonstrates
EPA induces Treg differentiation via PPAR-gamma upregulation; DHA-derived resolvin D1 promotes Treg over Th1 polarization that EPA promotes Treg differentiation through PPAR-gamma activation, while DHA-derived specialized pro-resolving mediators (resolvins, protectins) shift the Treg/Teffector balance toward immune tolerance.

For carriers of one or two risk alleles, proactive monitoring for autoimmune conditions is warranted, particularly given the variant's broad associations across organ-specific autoimmune diseases. Given the gut-immune connection, attention to food intolerances and intestinal symptoms may catch Treg-mediated mucosal immune dysfunction early.

Interactions

IL2RA rs2104286 operates within a broader network of autoimmune susceptibility genes. [Within the IL2RA locus | Fine-mapping studies identified multiple independent signals at IL2RA, including rs12722489 and rs11594656], rs12722489 represents a second, partially independent autoimmune signal. The two variants are in moderate linkage disequilibrium and may affect IL2RA expression through distinct regulatory mechanisms.

The combination of rs2104286 with CTLA4 rs3087243 (another immune checkpoint variant) is particularly relevant. Both variants impair Treg function through different mechanisms — IL2RA through reduced IL-2 signaling and CTLA4 through reduced co-inhibitory signaling — creating convergent Treg dysfunction. Similarly, PTPN22 rs2476601 disrupts T-cell activation thresholds through a separate pathway; carriers of risk alleles at both IL2RA and PTPN22 may have compounded autoimmune susceptibility through parallel Treg and Teffector dysregulation.